HOME
ABOUT WEX PHARMA
CONTACT US
About Us
Corporate Profile
Management
Directors
Corporate Governance
Contact
Products
About TTX
Pipeline
TTX for Cancer-Related Pain
TTX for Chemotherapy-Induced Neuropathic Pain
Scientific Publications
Clinical Trials
About TTX
TTX Clinical Experience
About Pain
Cancer-Related Pain
Chemotherapy-Induced Neuropathic Pain
The Drug Development Process
TTX Trials
TEC-006
TEC-007
Physician Resources
Investors
Press Releases
President's Messages
Stock Information
Financial Reports
Investor Presentations
Regulatory Filings
Factsheet
Investor Sign Up
Partnering
Opportunities
Partnering Contact
CLINICAL TRIALS:
THE EFFICACY AND SAFETY OF SUBCUTANEOUS TETRODOTOXIN FOR MODERATE TO SEVERE CANCER-RELATED PAIN
Latest
View All
NEWS
August 25, 2010
WEX Announces Poster Presentation at Scientific Conference
August 13, 2010
WEX Reports Second Quarter Results
July 19, 2010
President’s Message #12
July 12, 2010
WEX Receives Unsolicited Proposal to Purchase from Pharmagesic
INVESTOR RELATIONS:
TO VIEW OUR FINANCIAL REPORTS AND RECENT PRESS RELEASES CLICK HERE
Copyright WEX Phamaceuticals Inc. All Rights Reserved.
Privacy Policy
Disclaimer
Powered By Q4 Web Systems
3.5.9.1419